Navigation Links
ResMed Inc. Announces Record Financial Results for the Quarter Ended September 30, 2009
Date:11/5/2009

SAN DIEGO, Nov. 5 /PRNewswire-FirstCall/ -- ResMed Inc. (NYSE: RMD) today announced record revenue and income results for the quarter ended September 30, 2009. Revenue for the September 2009 quarter was $247.0 million, a 13% increase (a 16% increase on a constant currency basis) over the quarter ended September 30, 2008. For the quarter ended September 30, 2009, income from operations was $52.7 million and net income was $42.1 million, an increase of 44% and 50%, respectively, compared to the quarter ended September 30, 2008. Diluted earnings per share for the quarter ended September 30, 2009 was $0.55, an increase of 53% compared to the quarter ended September 30, 2008.

SG&A costs were $76.8 million for the September 2009 quarter, an increase of $5.4 million or 8% (an 11% increase on a constant currency basis) over the same period in the prior fiscal year. SG&A expenses were favorably impacted by the appreciation of the US dollar against international currencies. The increase in SG&A was primarily due to expenses necessary to support sales growth. SG&A costs were 31% of revenue in the September 2009 quarter, compared to 33% in the same period in the prior fiscal year.

R&D expenses were $17.9 million for the September 2009 quarter, or approximately 7% of revenue. R&D expenses increased by 4% (a 9% increase on a constant currency basis) compared to the prior year quarter. R&D expenses were positively impacted by the appreciation of the US dollar against international currencies, particularly the Australian dollar. The increase in research and development outlays reflects ResMed's continuing commitment to innovation within its product portfolio, as well as an ongoing commitment to clinical research and product development.

Amortization of acquired intangibles was $1.8 million ($1.2 mil
'/>"/>

SOURCE ResMed Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. ResMed Acquires Laboratoires Narval
2. Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT(R) Insert
3. Bionovo Announces Third Quarter 2009 Highlights and Financial Results
4. Jazz Pharmaceuticals Announces Third Quarter 2009 Financial Results
5. OTCBB-VHGI Announces LOI to Sell Certain Assets for $10 Million Cash/Stock to WNDM; With Stock Dividend to be Distributed to Shareholders in 2010
6. Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer
7. Reminder Webcast Alert: Transgenomic, Inc. Announces Third Quarter 2009 Earnings Release Conference Call Webcast
8. GSI Group Inc. Announces NASDAQ Delisting and Reports Progress on Revenue Recognition Review and Preliminary Third Quarter 2009 Bookings and Cash Balance
9. Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain Conference
10. Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results
11. InterMune Announces Submission of NDA for Pirfenidone for the Treatment of Patients with IPF
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... and NEW YORK and ... As the leading distributor of market intelligence, MarketResearch.com is ... report by IQ4I Research and Consultancy focusing on the ... more about IQ4I Research visit: http://www.marketresearch.com/land/publisher.asp?vendorid=4023&progid=86891 . ... Pharmaceutical Ingredients Global Market – Forecast to 2020 ...
(Date:11/26/2014)... 25, 2014  Medtronic,s roughly $43 billion ... widely discussed in the media for its US ... stronger leading player in one of the fastest ... healthcare market research firm said  the two companies ... diverse set of solutions spanning inpatient to home ...
(Date:11/26/2014)... Nov. 25, 2014  Breckenridge Pharmaceutical, Inc. announced ... ANDA agreement with Pii (Pharmaceutics International, Inc.) ( ... Breckenridge and Pii expect to develop and commercialize ... agreement, Pii will develop, manufacture and supply the ... products under its own label.  The drugs, comprised ...
Breaking Medicine Technology:MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 3Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 2Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 3Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with Pharmaceutics International, Inc. 2
... CHICAGO, Sept. 10 Celsis In Vitro, Inc. (Celsis ... for the Northern District of Illinois in Chicago has ... and Life Technologies (the Defendants) due to their infringement ... Technologies of Carlsbad, California (Nasdaq: LIFE ) ...
... eResearchTechnology, Inc. (ERT), (Nasdaq: ERES ), ... pharmaceutical, biotechnology, and medical device industries, today announced that ... President and Chief Executive Officer and a director of ... search for a successor.  Dr. McKelvey will continue in ...
Cached Medicine Technology:Celsis IVT Wins Preliminary Injunction Against Life Technologies and CellzDirect in Liverpool™ Patent Infringement Lawsuit 2Celsis IVT Wins Preliminary Injunction Against Life Technologies and CellzDirect in Liverpool™ Patent Infringement Lawsuit 3ERT Announces Upcoming Retirement of Michael McKelvey as Chief Executive Officer 2ERT Announces Upcoming Retirement of Michael McKelvey as Chief Executive Officer 3
(Date:11/27/2014)... is making every effort to offer more affordable but ... premier online supplier of elegant special occasion dresses and ... selection of sexy prom dresses today. In addition to ... beautiful styles in its product line. Click to buy ... “VogueQueen.com hopes to provide a truly unique shopping experience ...
(Date:11/27/2014)... 2014 Dr. Ronald Receveur, who has a ... few oral health tips before patients dig into the annual ... New Albany affordable cosmetic dentistry, and his staff ... and sugar. While the staff wishes everyone a happy and ... how patients can enjoy a feast that is also healthy ...
(Date:11/27/2014)... 27, 2014 Allowing children to help with ... school, helps give children responsibility, ownership, boosts self-esteem, and above ... , Now, the real question is, how do you encourage ... According to a study published by Child Development Journal, there ... dramatic effect on a child’s willingness to lend a hand. ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 Ethane Web ... has announced online reputation management service. , ... comprehensive study about the world of internet marketing and ... Yahoo. , Ethane Web Technologies does not work ... first analyzes the project to reach a conclusion what ...
(Date:11/27/2014)... November 26, 2014 Lintelus, Inc., ... platform, focused on increasing audience engagement at Convergence ... Lintelus’ software platform includes a multitude of interactive ... in a collaborative, interactive multi-screen environment. Best of ... presentation in real time on their own device. ...
Breaking Medicine News(10 mins):Health News:A New Collection of Sexy Prom Dresses Has Been Released by the Reliable Online Supplier VogueQueen.com 2Health News:New Albany Dental Practice Offers Oral Health Tips For Thanksgiving 2Health News:New Albany Dental Practice Offers Oral Health Tips For Thanksgiving 3Health News:New Albany Dental Practice Offers Oral Health Tips For Thanksgiving 4Health News:Ethane Web Technologies Announces Online Reputation Management Service 2Health News:Lintelus Showcases its Feature-Rich Presentation Technology Solution at Convergence Summit’s Annual Event in London 2
... PITTSBURGH, May 5 The University of Pittsburgh Cancer ... G. and Saul F. Shapira BRCA Cancer Research Program. ... mutated, dramatically increase the risk of breast, prostate, ovarian ... the addition of this research program to UPCI, said ...
... oceans play a vital role in the carbon cycle, ... enough to predict how our planet will react to ... humans are pumping into the atmosphere annually. , The ... of microscopic phytoplankton, marine plants that live in the ...
... and more with exclusive summer ... travel packages for 2008., SAN ... Kimpton Hotels & Restaurants Group announced today a,series of travel packages ... new KN Tranquility Suite(TM) offers opulent, comfort-inspired,surroundings in the heart of ...
... Attendance Doubles with More Than 175 Health Professionals From 13 ... ... ARAY ), a global leader in the field of radiosurgery, today,announced ... in,Boston, Massachusetts yielded record attendance with nearly double the,attendees over last ...
... to save a life, MINNEAPOLIS, May 5 ... the marrow Registry during the two weeks surrounding,Mother,s Day, ... campaign, kicks off today., For thousands of people ... offers a second chance at,life. Thanks Mom, which runs ...
... health status of enrollees, study says , , MONDAY, May ... insurance before enrolling in a U.S. government children,s health ... according to new research. , A waiting period ... (SCHIP), a federally funded program offering health insurance to ...
Cached Medicine News:Health News:Research program focuses on genetic mutations and cancer risk 2Health News:ESA contributes to ocean carbon cycle research 2Health News:KN Tranquility Suite(TM) Hosts Spa Indulgences and High-Tea Service on the Magnificent Mile 2Health News:KN Tranquility Suite(TM) Hosts Spa Indulgences and High-Tea Service on the Magnificent Mile 3Health News:Robotic Radiosurgery Course Yields Record Attendance 2Health News:Robotic Radiosurgery Course Yields Record Attendance 3Health News:Robotic Radiosurgery Course Yields Record Attendance 4Health News:National Marrow Donor Program(R) Kicks off National Awareness Campaign 2Health News:National Marrow Donor Program(R) Kicks off National Awareness Campaign 3Health News:Federal Health Plan for Children Still Leaves Needs Unmet 2
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
Medicine Products: